STUDY SEARCH RESULTS

1 study found for your search request:  0482-002

A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomon...
Condition: Relapsed or refractory acute myeloid leukemia, Relapsed or refractory chronic myelomonocytic leukemia
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05038800
Status: Terminated (Halted Prematurely)




Copyright © 2026 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site